Clinical Trial Update: A Study of the Effectiveness of Risk Minimization Measures Related to Depakine® (Sodium Valproate) in Saudi Arabia

View source ↗

Summary

A clinical trial update assessing the effectiveness of risk minimization measures for Depakine (sodium valproate) in Saudi Arabia.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Epilepsy
• Seizures

Drugs mentioned

• Depakine (sodium valproate)

Snippet

Sponsor: Sanofi | Conditions: Epilepsy, Seizures | Status: ACTIVE_NOT_RECRUITING